75 related articles for article (PubMed ID: 25501506)
1. RAB34 was a progression- and prognosis-associated biomarker in gliomas.
Wang HJ; Gao Y; Chen L; Li YL; Jiang CL
Tumour Biol; 2015 Mar; 36(3):1573-8. PubMed ID: 25501506
[TBL] [Abstract][Full Text] [Related]
2. EPHB2 as a key mediator of glioma progression: Insights from microenvironmental receptor ligand-related prognostic gene signature.
Tan L; Zhou J; Nie Z; Li D; Wang B
Genomics; 2024 May; 116(3):110799. PubMed ID: 38286348
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional expression of ZICs as an independent indicator of survival in gliomas.
Han Z; Jia J; Lv Y; Wang R; Cao K
Sci Rep; 2021 Sep; 11(1):17532. PubMed ID: 34475426
[TBL] [Abstract][Full Text] [Related]
4. Expression and Prognostic Role of PANK1 in Glioma.
Zhao Z; Xu X; Ma S; Li L
Comb Chem High Throughput Screen; 2024; 27(5):715-724. PubMed ID: 37138430
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic value of long non-coding RNA H19 in glioma via integrated bioinformatics analyses.
Xiao Y; Zhu Z; Li J; Yao J; Jiang H; Ran R; Li X; Li Z
Aging (Albany NY); 2020 Feb; 12(4):3407-3430. PubMed ID: 32081833
[TBL] [Abstract][Full Text] [Related]
6. CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in high‑grade glioma.
Wang K; Huang R; Li G; Zeng F; Zhao Z; Liu Y; Hu H; Jiang T
Oncol Rep; 2018 Oct; 40(4):2036-2046. PubMed ID: 30066946
[TBL] [Abstract][Full Text] [Related]
7. Novel roles of VAT1 expression in the immunosuppressive action of diffuse gliomas.
Yang P; Wang K; Zhang C; Wang Z; Liu Q; Wang J; Jiang T; Shan X
Cancer Immunol Immunother; 2021 Sep; 70(9):2589-2600. PubMed ID: 33576871
[TBL] [Abstract][Full Text] [Related]
8. The m6A reader HNRNPC promotes glioma progression by enhancing the stability of IRAK1 mRNA through the MAPK pathway.
Chen JJ; Lu TZ; Wang T; Yan WH; Zhong FY; Qu XH; Gong XC; Li JG; Tou FF; Jiang LP; Han XJ
Cell Death Dis; 2024 Jun; 15(6):390. PubMed ID: 38830885
[TBL] [Abstract][Full Text] [Related]
9. CDCA3 is a potential biomarker for glioma malignancy and targeted therapy.
Han C; Liu S; Ji Y; Hu Y; Zhang J
Medicine (Baltimore); 2024 May; 103(19):e38066. PubMed ID: 38728485
[TBL] [Abstract][Full Text] [Related]
10. Identification and classification of glioma subtypes based on RNA-binding proteins.
Liu X; Wu L; Wang L; Li Y
Comput Biol Med; 2024 May; 174():108404. PubMed ID: 38582000
[TBL] [Abstract][Full Text] [Related]
11. THOC6 is a novel biomarker of glioma and a target of anti-glioma drugs: An analysis based on bioinformatics and molecular docking.
Wei C; Gao Y; Li P
Medicine (Baltimore); 2024 May; 103(19):e37999. PubMed ID: 38728502
[TBL] [Abstract][Full Text] [Related]
12. Integrative analysis of bulk RNA-seq and scRNA-seq data indicates the prognostic and immunologic values of SERPINH1 in glioma.
Hou S; Chen Y; Jin C; Lin N
Environ Toxicol; 2024 Jun; 39(6):3654-3665. PubMed ID: 38506564
[TBL] [Abstract][Full Text] [Related]
13. TSPAN6 could serve as a prognostic biomarker for patients with glioma.
Zeng X; Xie Y; Xie Y; Zhang C
Asian J Surg; 2024 May; 47(5):2250-2252. PubMed ID: 38403542
[No Abstract] [Full Text] [Related]
14. TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.
Han MZ; Xu R; Xu YY; Zhang X; Ni SL; Huang B; Chen AJ; Wei YZ; Wang S; Li WJ; Zhang Q; Li G; Li XG; Wang J
J Exp Clin Cancer Res; 2017 Nov; 36(1):155. PubMed ID: 29110682
[TBL] [Abstract][Full Text] [Related]
15. E2F1‑mediated RAB34 upregulation accelerates the proliferation and inhibits the cell cycle arrest and apoptosis of acute myeloid leukemia cells.
Xiong X; Jian G
Exp Ther Med; 2023 Aug; 26(2):389. PubMed ID: 37456160
[TBL] [Abstract][Full Text] [Related]
16. MT1-MMP Expression Levels and Catalytic Functions Dictate LDL Receptor-Related Protein-1 Ligand Internalization Capacity in U87 Glioblastoma Cells.
Pratt J; Haidara K; Annabi B
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430705
[TBL] [Abstract][Full Text] [Related]
17. RNA-seq and ChIP-seq Identification of Unique and Overlapping Targets of GLI Transcription Factors in Melanoma Cell Lines.
Kurtović M; Piteša N; Bartoniček N; Ozretić P; Musani V; Čonkaš J; Petrić T; King C; Sabol M
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139698
[TBL] [Abstract][Full Text] [Related]
18. The Progression Related Gene
Sun L; Yan T; Yang B
Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741652
[TBL] [Abstract][Full Text] [Related]
19. HSPA6 is Correlated With the Malignant Progression and Immune Microenvironment of Gliomas.
Zhou X; Ji Q; Li Q; Wang P; Hu G; Xiao F; Ye M; Lin L; Luo M; Guo Y; Wu W; Huang K; Guo H
Front Cell Dev Biol; 2022; 10():833938. PubMed ID: 35281087
[TBL] [Abstract][Full Text] [Related]
20. OSlgg: An Online Prognostic Biomarker Analysis Tool for Low-Grade Glioma.
An Y; Wang Q; Zhang L; Sun F; Zhang G; Dong H; Li Y; Peng Y; Li H; Zhu W; Ji S; Wang Y; Guo X
Front Oncol; 2020; 10():1097. PubMed ID: 32775301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
